304results about How to "Reduce appetite" patented technology

Methods for treating conditions or disorders which can be alleviated by reducing food intake are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that affect satiety. The methods are useful for treating conditions or disorders, including obesity, Type II diabetes, eating disorders, and insulin-resistance syndrome. The methods are also useful for lowering the plasma glucose level, lowering the plasma lipid level, reducing the cardiac risk, reducing the appetite, and reducing the weight of subjects. Pharmaceutical compositions for use in the methods of the invention are also disclosed.

Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.

Methods are disclosed for decreasing calorie intake, food intake, and appetite in a subject. The methods include peripherally administering a therapeutically effective amount of PYY or an agonist thereof to the subject, thereby decreasing the calorie intake of the subject.

ACE-2 modulating compounds for the treatment of body weight disorders are disclosed. Methods of using the compounds and pharmaceutical compositions containing the compounds are also claimed.

The invention discloses a medicament for treating breast cancer, which comprises the following raw materials: costus root, rhizoma cyperi, radix curcumae, dried orange peel, cortex magnoliae officinalis, dangshen, fried bighead atractylodes rhizome, glossy privet fruit, angelica, milk vetch, Chinese wolfberry, radix scutellariae, coptis, tuber pinellia, morel, solanum lyratum, bupleurum, agrimony, radix rehmanniae, barbed skullcap herb, dandelion, oyster, prepared turtle shell, forsythia, euphorbia helioscopia, citron, corydalis tuber, rhizoma bolbostemmae, American ginseng, white peony root, licorice, glabrous greenbrier rhizome, chuanxiong rhizome, mint, buttercup root, tulip bulb, sarcandra glabra, prunella vulgaris, gizzard pepsin, common burreed rhizome, rhizoma zedoariae, red sage root, fried mastic and fried myrrh. The medicament disclosed by the invention has an obvious effect on treating breast cancer, can be used for treating both principal and secondary aspects of the disease, has the functions of inhibiting the growth and migration of cancer cells, improving the gastrointestinal functions of patients and improving the immunity, and does not have toxic side reactions. The effective rate reaches 92.6%, and the effect taking rate reaches 75%. The medicament disclosed by the invention has the characteristics of exact effect and low price, can be used for quickly curing the breast cancer, and can be easily accepted by patients.

The present invention is concerned with deuterium-enriched sulfonamides of formula 1, their pharmaceutically acceptable salts and methods of use thereof for the treatment of anxiety disorders including, General Anxiety Disorder (GAD), Panic Disorder (PD), Post-Traumatic Stress Disorder (PTSD), Social Phobia (SP), Health Anxiety (Hypochondriasis), depression, major depressive disorders, unipolar depression, bipolar I depression disorder, bipolar II depression disorder, treatment-resistant depression, single episodic and recurrent major depressive disorders, depression in the medically ill, attention deficit hyperactivity disorder (ADHD), attention deficit disorder (ADD), Obsessive-Compulsive Disorder (OCD), Obsessive-Compulsive Personality Disorder (OCPD), Autism Spectrum Disorder (ASD), schizophrenia, psychosis, epilepsy, seizures, hot flashes due to menopause, age-related macular degeneration (AMD), premature ejaculation, male erectile dysfunction, sexual dysfunction, obesity, eating disorders, bulimia nervosa, anorexia nervosa, angina, migraine, pain, nociception, sleep disorders, insomnia, fibromyalgia, alcohol withdrawal, autism, Rett's syndrome, cyclothymic disorder, neural injury, neurodegenerative diseases, Parkinson's disease, Parkinson's disease psychosis, Huntington disease, Alzheimer's disease, frontotemporal dementia, cognitive impairment associated with age-related dementia, Alzheimer's disease, schizophrenia, psychosis, depression, pain or discomfort associated with surgery and pain or discomfort associated with medical illness.

The invention discloses a nitrite-substituted meat processing method, and belongs to the technical field of food processing. The nitrite-substituted meat processing method comprises the following steps: selecting raw materials, carrying out pickling treatment and processing a meat product, so that the final products of the meat product are prepared; and the nitrite is substituted by a nitrite substitute during the step of carrying out pickling treatment. The nitrite substitute comprises the following components in parts by weight: 4-5 parts of monascorubin, 0.7-1.3 parts of betanin, 4-6 parts of potassium sorbate, 2-3 parts of D-sodium isoascorbate, 1.5-2.5 parts of nisin, 9-11 parts of sodium lactate, 1-2 parts of natamycin, 5-6 parts of natural vitamin E, 1-2 parts of a rosemary extract, 0.5-1.5 parts of sage essential oil, 1-2 parts of tea polyphenols, 15-16 parts of L-sodium glutamate, 0.5-1.5 parts of flavoring 5'-disodium ribonucleotide, 40-43 parts of a yeast extract, 4-5 parts of sodium tripolyphosphate and 0.5-1.5 parts of ethyl maltol. The nitrite-substituted meat processing method disclosed by the invention is simple, easy to operate and free of nitrite addition; and the prepared meat products are very good in qualities, color, luster and taste.

The invention discloses a composite premix for pigs and belongs to the technical field of feeds. The composite premix for pigs comprises a carrier, mineral matters, composite vitamin, amino acid, an anti-oxidant, phytase, antibacterial peptide and phytosterol. The mineral matters comprise trace element mineral matter and constant element mineral matter. The composite premix for pigs contains no antibiotic but antibacterial peptide and phytosterol. The trace elements adopted in the invention are mainly organic trace elements. Weighed according to a ratio, components of the composite premix forpigs can perform a synergistic effect, so as to avoid the antagonistic effect, raise utilization rate of additives such as trace elements for live pigs, save limited resources of inorganic mineral feeds, substantially improve the ecological environment around a pig farm, simultaneously reduce deposition of the trace elements in pigs, raise the quality of pork and guarantee the health of consumers.